Skip to main content
. 2014 Aug 17;14(8):e10813. doi: 10.5812/hepatmon.10813

Figure 2. Association Between Hepatic B Virus Genotype and Antiviral Efficacy of Adefovir Dipivoxil.

Figure 2.

To compare the response of HBV genotypes B and C to ADV, the HBV DNA seroclearance rate (< 500 IU/mL) (A), HBV DNA decline rate (> 3 lg IU/mL) (B), HBV DNA level (C), ALT normalization rate (D), HBeAg seroclearance rate (E), and the HBeAg seroconversion rate (F) in adefovir dipivoxil and placebo groups were assessed after treatment for three, six, and 12 months. *, P ≤ 0.05 was considered statistically significant. The values are expressed as means ± SE.